CBOE in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with CBOE today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Options are Cboe Global Markets’ largest business. Brokers, market makers and investment firms use its markets to trade and manage financial risk, paying fees when trades execute. Its exclusive SPX options on the S&P 500 Index and its VIX options and futures account for much of its options-and-futures business. SPX options let customers manage stock-market exposure, while VIX products let them trade or hedge changes in expected market volatility.
Cboe also operates stock and institutional foreign-exchange markets. Its clearinghouses earn fees by handling clearing and settlement; Cboe Clear Europe stands between buyers and sellers and guarantees settlement obligations, including for trades on other venues. Beyond transactions, Cboe Data Vantage charges customers for market data and connections to its trading systems, and Cboe licenses indices for use in financial products.
Most revenue comes from transaction and clearing fees, so the business depends on customers continuing to send trades to its markets. A small group of large customers supplies a substantial share of revenue. The SPX business depends on exclusive licenses from S&P Dow Jones Indices, and the VIX business depends on Cboe’s proprietary methodology rights. All options traded on its exchanges must clear through OCC. Regulation also limits its flexibility: U.S. securities market-data and access-fee changes generally must be filed with the SEC, and regulators can delay or reject exchange rule changes.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
CME Group competes with Cboe for traders managing financial risk, charging for equity-index derivatives trading, institutional currency trading, clearing trades and market data. Watch CME’s equity-index and currency trading volumes for the competitive backdrop to Cboe’s SPX options and institutional FX business.
Nasdaq competes with Cboe for options and cash-equity trades and sells market data to overlapping trading customers, putting both trading fees and data revenue in play. Watch its options and equity trading activity and sales of quote and trade data, rather than its broader technology business.
Miami International Holdings’ MIAX exchanges compete with Cboe for broker-dealers’ U.S. options and cash-equity orders, which generate trading fees. Watch MIAX’s fees and rebates for options traded on multiple exchanges: this competition has historically reduced Cboe’s net revenue per contract in those products.
Intercontinental Exchange competes with Cboe for equity-options trades, ETF listings and financial-market data customers, contesting its trading, listing and data revenue. Its options trading, ETF listings and data sales to financial institutions are the relevant businesses to watch—not its mortgage technology operations.
Cboe depends on S&P Global’s index business for permission to use the benchmarks behind its exclusive SPX options and related volatility products, which earn fees from traders. Watch the licensing terms: Cboe’s S&P license runs through December 31, 2033, but its exclusive right to trade S&P 500 Index options runs through December 31, 2032.
Tradeweb Markets and Cboe both earn trading-related revenue from institutional clients using electronic marketplaces, so institutional trading volumes and the shift to electronic execution matter to both, despite different principal asset classes. Watch Tradeweb’s institutional trading activity alongside Cboe’s institutional currency and U.S. government-securities trading, rather than treating it as a direct SPX options rival.
CME Group Inc. earningsCME
CME’s equity-index and currency derivatives volumes will show how demand for trading financial risk is changing, a competitive backdrop for Cboe’s SPX options and institutional FX businesses.
Check whether CME’s equity-index and currency volumes rise or fall. Strength in both would point to active demand for hedging, a supportive but competitive market for Cboe’s SPX options and institutional FX—not proof that Cboe wins more orders. Weakening volumes would point to cooler demand in those shared risk-trading markets. The takeaway is the direction of the market backdrop, not Cboe’s own results.
S&P Global Inc. earningsSPGI
S&P Global’s index business licenses benchmarks used in Cboe’s SPX options and related volatility products, so its report may signal whether that licensing relationship is changing.
Watch S&P Global’s comments on index licensing and demand, and whether it discloses any change involving Cboe or SPX license terms. Steady index activity with no reported change leaves the licensing basis for those products apparently intact; tighter terms or changed exclusivity would add uncertainty to Cboe’s fee-generating SPX products. No disclosure does not prove the contract is unchanged; the question is whether the report signals a change in the licensing foundation.
Miami International Holdings, Inc. earningsMIAX
Miami International Holdings’ MIAX exchanges compete with Cboe for multi-listed options orders, and their fees and rebates will show whether pressure on revenue per contract is intensifying.
Watch MIAX’s fees and rebates for multi-listed options alongside related trading activity. Lower fees or richer rebates with stronger activity would show exchanges pressing harder for orders, potentially weighing on Cboe’s net revenue per contract or order share. Steadier pricing without stronger activity would offer no sign that this pressure is intensifying. The takeaway is whether price competition in multi-listed options is tightening; MIAX’s revenue per contract is not a proxy for Cboe’s.
Cboe Global Markets, Inc. earningsThis company
Cboe earns most of its revenue less cost of revenues from options and futures, and this report will show whether trading activity is still turning into fees.
Read average daily options and futures volume alongside transaction and clearing revenue. If both rise together, Cboe’s SPX- and VIX-centered products are still converting trading demand into fees. If volume rises but fee revenue lags, volume-tier discounts, product mix or index royalties may be diluting revenue per trade. Together, those figures show whether the core derivatives business is expanding or its growth is weakening.